Today: 21 May 2026
Browse Category

NASDAQ:CRWD 17 December 2025 - 1 January 2026

CrowdStrike stock slides after-hours as Wedbush keeps CRWD on its top AI picks list

CrowdStrike stock slides after-hours as Wedbush keeps CRWD on its top AI picks list

CrowdStrike shares last traded at $468.76, down 1.5% after the New Year’s holiday market closure. Analyst Dan Ives of Wedbush reiterated a $600 price target, citing AI-driven security demand. Sector peers Palo Alto Networks and Fortinet also fell. Investors await early January U.S. economic data and CrowdStrike’s next results for updates on subscription growth.
CrowdStrike stock (CRWD) slips after hours as CEO pay filing and Wedbush’s $600 target hit year-end tape

CrowdStrike stock (CRWD) slips after hours as CEO pay filing and Wedbush’s $600 target hit year-end tape

CrowdStrike shares fell 1.5% after hours to $468.76 following disclosure of a new performance-based equity award for CEO George Kurtz, tied to S&P 500-relative returns through 2028. Analyst Dan Ives of Wedbush reiterated a $600 price target, calling CrowdStrike a key AI-linked cybersecurity play for 2026. Palo Alto Networks, Zscaler, and Fortinet also traded lower late Wednesday. U.S. markets are closed Thursday for New Year’s Day.
CrowdStrike stock slips as CEO George Kurtz gets new performance award tied to $20B ARR goal

CrowdStrike stock slips as CEO George Kurtz gets new performance award tied to $20B ARR goal

CrowdStrike disclosed a new performance-based equity award for CEO George Kurtz, potentially delivering up to 600,000 shares if the stock outperforms most of the S&P 500 over three years, according to an SEC filing. Shares closed down 1.1% at $475.91 on Monday. Chief Accounting Officer Anurag Saha sold 836 shares at $476.83 on Dec. 24. Investors await Fed minutes as holiday trading thins.
CrowdStrike stock ends higher as Wedbush backs AI tailwind; Zacks cuts rating to hold

CrowdStrike stock ends higher as Wedbush backs AI tailwind; Zacks cuts rating to hold

CrowdStrike shares closed Friday up 0.8% at $481.19 in light post-holiday trading. Wedbush reiterated an “Outperform” rating and $600 price target, citing AI momentum, while Zacks Research lowered its rating to “hold.” Investors await pending home sales data Monday and Federal Reserve minutes Tuesday. Trading volumes remain thin as year-end approaches.
CrowdStrike (CRWD) Stock Update: Weekend Wrap, Fresh Analyst Calls, and What to Watch When Markets Reopen

CrowdStrike (CRWD) Stock Update: Weekend Wrap, Fresh Analyst Calls, and What to Watch When Markets Reopen

CrowdStrike closed Friday at $481.19, up 0.84%, as Wall Street weighed mixed analyst calls ahead of Monday’s session. Zacks downgraded the stock to “Hold” on Dec. 27, while Wedbush reiterated an “Outperform” rating with a $600 target. CRWD trades near its 200-day moving average, with a 52-week range of $298 to $566.90 and a market cap near $121 billion.
28 December 2025
CrowdStrike (CRWD) Stock News Today: Market Closed Weekend as Wedbush Reiterates $600 Target, Options Flow Signals Cautious Positioning

CrowdStrike (CRWD) Stock News Today: Market Closed Weekend as Wedbush Reiterates $600 Target, Options Flow Signals Cautious Positioning

CrowdStrike closed Friday at $481.19, up 0.86%, with about 1.15 million shares traded ahead of the holiday weekend. Wedbush reiterated its Outperform rating and $600 price target, citing strong AI-driven demand. Options scanners flagged heavy, mostly bearish activity in CRWD contracts Friday. Institutional headlines centered on quarterly position disclosures, not fresh buying.
27 December 2025
CrowdStrike (CRWD) Stock News: AI Tailwinds, AWS Wins, Insider Sales, and Analyst Forecasts as Wall Street Heads Into the Next Session

CrowdStrike (CRWD) Stock News: AI Tailwinds, AWS Wins, Insider Sales, and Analyst Forecasts as Wall Street Heads Into the Next Session

CrowdStrike shares last traded at $481.19, up 0.8% after a session between $475 and $482, as U.S. stock markets closed for the weekend. The company recently raised its Q4 revenue outlook to $1.29–$1.30 billion, above analyst estimates, citing AI-driven growth. Full-year guidance now stands at $4.80–$4.81 billion. Regular trading resumes Monday, December 29.
CrowdStrike (CRWD) Stock Today: Latest News, Analyst Forecasts, and What to Watch Into the Close

CrowdStrike (CRWD) Stock Today: Latest News, Analyst Forecasts, and What to Watch Into the Close

CrowdStrike shares traded near $480.94, up 0.8% Friday afternoon in New York, as U.S. markets saw light post-holiday volume. The move follows strong fiscal Q3 results, with CrowdStrike reporting $1.23 billion in revenue and record net new annual recurring revenue. Major indexes hovered near record highs. Investors watched for signs of a continued year-end rally.
26 December 2025
CrowdStrike Stock (CRWD) News Today: AI Security Push, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025

CrowdStrike Stock (CRWD) News Today: AI Security Push, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025

CrowdStrike shares traded near $478 on Dec. 23, down about 1% amid a tight intraday range. The company recently launched Falcon AI Detection and Response, targeting enterprise AI security. Analysts say strong fundamentals persist, but investors remain cautious about high valuations in a selective market. No new earnings were reported Tuesday.
CrowdStrike (CRWD) Stock Week Ahead: AI Security Momentum, Fresh Partnership Tailwinds, and the Key Drivers for Dec. 22–26, 2025

CrowdStrike (CRWD) Stock Week Ahead: AI Security Momentum, Fresh Partnership Tailwinds, and the Key Drivers for Dec. 22–26, 2025

CrowdStrike traded near $481 Monday, as investors weighed its AI-driven product expansion against high valuation risks. A Dec. 21 note highlighted new integrations with Amazon Business Prime and SailPoint, and pegged “narrative fair value” at $533. Q3 results showed $1.23B revenue, up 22% year-over-year, and record cash flow. Management raised full-year guidance, citing strong Falcon Flex adoption.
Cybersecurity Stocks Week Ahead: Palo Alto Networks, CrowdStrike, Fortinet, Zscaler and Okta in Focus (Dec. 22–26, 2025)

Cybersecurity Stocks Week Ahead: Palo Alto Networks, CrowdStrike, Fortinet, Zscaler and Okta in Focus (Dec. 22–26, 2025)

U.S. stock markets will close early Dec. 24 and remain shut Dec. 25, with thin trading expected. Palo Alto Networks deepened its Google Cloud partnership and won German approval for its CyberArk acquisition. Fortinet vulnerabilities drew new warnings, while Okta-linked social engineering attacks intensified. Wall Street flagged strong cybersecurity platform performance but raised concerns about valuations.
CrowdStrike Stock (CRWD) News, Forecasts and Analyst Outlook: What’s Driving Shares as of Dec. 20, 2025

CrowdStrike Stock (CRWD) News, Forecasts and Analyst Outlook: What’s Driving Shares as of Dec. 20, 2025

CrowdStrike shares closed at $481.28 on Dec. 19, 2025, after trading as high as $489.20, with volume near 4.64 million shares. The stock’s movement follows strong Q3 FY2026 results: revenue rose 22% to $1.234 billion, and the company raised full-year guidance. Wall Street focus remains on annual recurring revenue and the pace of new customer growth amid ongoing AI-driven product expansion.
21 December 2025
CrowdStrike (CRWD) Stock News and Forecast on Dec. 20, 2025: Analyst Targets, Earnings Outlook, and AI Catalysts

CrowdStrike (CRWD) Stock News and Forecast on Dec. 20, 2025: Analyst Targets, Earnings Outlook, and AI Catalysts

CrowdStrike shares closed at $481.28 on Dec. 19, up 0.84%, with after-hours trading at $483.00. DA Davidson reiterated a Buy rating and $580 price target, citing strong ARR growth. For Q3 FY2026, CrowdStrike reported $1.232 billion in revenue and a GAAP net loss of $34 million. The stock remains about 15% below its 52-week high.
CrowdStrike (CRWD) Stock After Hours: Today’s Headlines, Analyst Forecasts, and What to Watch Before the Dec. 19, 2025 Market Open

CrowdStrike (CRWD) Stock After Hours: Today’s Headlines, Analyst Forecasts, and What to Watch Before the Dec. 19, 2025 Market Open

CrowdStrike shares closed Thursday up 1.54% at $477.26, then slipped 0.16% to $476.52 after hours. Trading volume was 1.8 million shares, below the 50-day average. Amazon Business Prime added CrowdStrike Falcon Go as a benefit for eligible members, while SailPoint announced new integrations with CrowdStrike’s Falcon platform. The stock remains about 15.8% below its 52-week high.
19 December 2025
CrowdStrike (CRWD) Stock After the Bell on Dec. 17, 2025: After-Hours Update, Today’s Key News, and What to Watch Before Thursday’s Open

CrowdStrike (CRWD) Stock After the Bell on Dec. 17, 2025: After-Hours Update, Today’s Key News, and What to Watch Before Thursday’s Open

CrowdStrike shares fell 3.79% to $470.02 on Wednesday, closing about 17% below last month’s high. Trading volume was 2.3 million, slightly under the 50-day average. After-hours trading showed little change, with prices hovering near the close. Cybersecurity peers Fortinet and Palo Alto Networks also declined, as tech stocks faced broad selling pressure.
18 December 2025
CrowdStrike Stock (CRWD) News Today — Dec. 17, 2025: Falcon AIDR AI Security Launch, Analyst Forecasts, Options Signals, and What’s Moving Shares

CrowdStrike Stock (CRWD) News Today — Dec. 17, 2025: Falcon AIDR AI Security Launch, Analyst Forecasts, Options Signals, and What’s Moving Shares

CrowdStrike shares fell 2.85% to $474.62 midday Wednesday after the company announced general availability of Falcon AIDR, a new AI security product targeting prompt and agent attacks. Trading volume reached about 1.2 million shares. The move follows recent coverage of product expansion, updated institutional ownership, and a credit-rating note. No new earnings were reported; last results came Dec. 2.

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop